covid vaccine novavax

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

· 1d · on MSN

AARP · 2d

Third COVID Vaccine Gets Approved for Adults 65 and Over

· 4d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

FDA may limit future Covid-19 shots to older people and those at risk of serious infection

Millions of healthy adults and kids will likely lose access to updated vaccines under the new criteria.

· 1d

· 1h

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

1don MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

STAT3d

Novavax wins narrowed approval for its Covid-19 shot after delay

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.